- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Jim Cramer let us know that he is not big on retail.
New bowel drug Trulance will be available for patients later this quarter.
The pharmaceutical company's new strategy emphasizes new product launches and international expansion.